Related Experiment Video
Updated: Apr 19, 2026

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
[Expression of MiRNA-21 in diffuse large B cell lymphoma and its significance]
Guo-Qi Song1, Ling Gu1, Bang-Shun He1
1Department of Internal Medicine, Southeast University Medical Shool, Nanjiang 210009, Jiangsu Province, China.
Abstract:
MicroRNA-21 (miR-21) is considered to play a key role in many cellular processes, affecting tumorigenesis by inhibiting target gene expression. However, its role in diffuse large B-cell lymphoma (DLBCL) is still unclear, and there are no in depth studies on relationship between miR-21 and cellular phenotype. This study was aimed to investigated the expression and role of miR-21 in the regulation of cell biological behavior in DLBCL. The expressions of miR-21 in three DLBCL cell lines were detected by real-time quantitative reverse-transcription polymerase chain reaction (qRT-PCR). The possible roles of miR-21 in the biological and behavioral properties of DLBCL were explored by transfection of anti-miR-21 for miR-21 knockdown. In addition, PDCD4 and PTEN were assessed by luciferase reporter assay, qRT-PCR and Western blot. The results revealed that miR-21 expression was significantly upregulated in activated B-cell-like DLBCL cells as compared to germinal centre-like DLBCL cells. The inhibition of miR-21 could induce suppression of proliferation and invasion, as well as increase apoptosis in DLBCL. Moreover, knockdown of miR-21 increased the expressions of PDCD4 and PTEN at the protein level but not at the mRNA level. It is concluded the miR-21 can regulate proliferation, invasion, and apoptosis, so it has a potential therapeutic application in DLBCL.
Insights
MicroRNA-21 (miR-21) is upregulated in diffuse large B-cell lymphoma (DLBCL) and drives cancer cell proliferation and invasion. Inhibiting miR-21 suppressed DLBCL growth and increased apoptosis, suggesting therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- MicroRNA-21 (miR-21) is implicated in tumorigenesis by regulating gene expression.
- The specific role of miR-21 in diffuse large B-cell lymphoma (DLBCL) and its impact on cellular phenotype remain largely uncharacterized.
Purpose of the Study:
- To investigate the expression levels of miR-21 in DLBCL cell lines.
- To elucidate the role of miR-21 in regulating the biological behavior of DLBCL cells.
- To explore the potential therapeutic applications of targeting miR-21 in DLBCL.
Main Methods:
- Real-time quantitative reverse-transcription polymerase chain reaction (qRT-PCR) to measure miR-21 expression.
- Transfection with anti-miR-21 to achieve miR-21 knockdown in DLBCL cell lines.
- Luciferase reporter assay, qRT-PCR, and Western blot to assess PDCD4 and PTEN expression.
Main Results:
- miR-21 expression was significantly higher in activated B-cell-like DLBCL cells compared to germinal centre-like DLBCL cells.
- Inhibition of miR-21 led to decreased proliferation and invasion, and increased apoptosis in DLBCL cells.
- Knockdown of miR-21 resulted in elevated protein levels of PDCD4 and PTEN, but not their mRNA levels.
Conclusions:
- miR-21 plays a significant role in regulating proliferation, invasion, and apoptosis in DLBCL.
- Targeting miR-21 demonstrates potential as a therapeutic strategy for DLBCL treatment.
Related Concept Videos
Abnormal Proliferation
MicroRNAs

